Description
JH-II-127 is a selective inhibitor of leucine-rich repeat kinase 2 (LRRK2), a potential therapeutic target for neurodegenerative disease. It inhibits phosphorylation of Ser910 and Ser935 in both wild-type LRRK2 and the G2019S mutant.
Product Unit Size | Cost | Quantity | Stock |
---|
JH-II-127 is a selective inhibitor of leucine-rich repeat kinase 2 (LRRK2), a potential therapeutic target for neurodegenerative disease. It inhibits phosphorylation of Ser910 and Ser935 in both wild-type LRRK2 and the G2019S mutant.
Cas No. | 1700693-08-8 |
---|---|
Purity | ≥98% |
Formula | C19H21ClN6O3 |
Formula Wt. | 416.87 |
IUPAC Name | (4-{[5-Chloro-4-(methylamino)-3H-pyrrolo[2,3-d]pyrimidin-2-yl]amino}-3-methoxyphenyl)(4-morpholinyl)methanone |
Synonym | Pyrrolopyrimidine |
Solubility | DMSO |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Hatcher J., Zhang J., et al. Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 Inhibitor. ACS Med Chem Lett. 6(5):584-9 (2015). PMID: 26005538.
Endogenous peptide hormone, involved in feeding...
BH3 mimetic; Bcl-2 and Bcl-xl inhibitor.
Folate analog; thymidylate synthase inhibitor.<...
FXR agonist.
Diterpene found in brewed, unfiltered coffee; F...
Indole; Src inhibitor.
Octapeptide derived from activity-dependent neu...
Synthetic steroid hormone used in HRT; SERM, PR...
mTORC1 inhibitor.
Anthracenedione, DNA intercalator; Pim-1 inhibi...
JAK2 inhibitor.
Synthesis impurity
Melatonin analog; MT1/2 agonist, 5-HT2C antagon...
Protein translation inhibitor, peptidyl transfe...
Endogenous peptide hormone, glugagon fragment; ...
Methylxanthine; PDE inhibitor, A1/2 adenosine a...
Non-steroid; AR antagonist.
FIASMA, SERT and DAT inhibitor, α1-adrenergic ...
Calcium channel blocker.
Tenoxicam impurity